Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield
JNCI Cancer Spectrum · 2024
DOI: 10.1093/jncics/pkae043 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2024. Verfasst von Carl Bonander und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Sweden. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Colonoscopy, Early Detection of Cancer, Occult Blood. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swedish Research Council for Health, Working Life and Welfare.
Abstract (Originalsprache)
Background
Socioeconomic inequalities in the uptake of colorectal cancer screening are well documented, but the implications on inequities in health gain remain unclear.
Methods
Sixty-year-olds were randomly recruited from the Swedish population between March 2014 and March 2020 and invited to undergo either 2 rounds of fecal immunochemical testing (FIT) 2 years apart (n = 60 137) or primary colonoscopy just once (n = 30 400). By linkage to Statistics Sweden’s registries, we obtained socioeconomic data. In each defined socioeconomic group, we estimated the cumulative yield of advanced neoplasia in each screening arm (intention-to-screen analysis). In the biennial FIT arm, we predicted the probability of exceeding the yield in the primary colonoscopy arm by linear extrapolation of the cumulative yield to (hypothetical) additional rounds of FIT.
Results
In the lowest income group, the yield of advanced neoplasia was 1.63% (95% confidence interval [CI] = 1.35% to 1.93%) after 2 rounds of FIT vs 1.93% (95% CI = 1.49% to 2.40%) in the primary colonoscopy arm. Extrapolation to a third round of FIT implied a 86% probability of exceeding the yield in the primary colonoscopy arm. In the highest income group, we found a more pronounced yield gap between the 2 screening strategies—2.32% (95% CI = 2.15% to 2.49%) vs 3.71% (95% CI = 3.41% to 4.02%)— implying a low (2%) predicted probability of exceeding yield after a third round of FIT.
Conclusions
Yield of advanced neoplasia from 2 rounds of FIT 2 years apart was poorer as compared with primary colonoscopy, but the difference was less in lower socioeconomic groups. Clinical Trial Registration ClinicalTrials.gov identifier NCT02078804
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Sweden.
- Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
- Department of Medicine K2, Karolinska Institutet, Solna, Sweden.
ORCID-Profile: Carl Bonander, Marcus Westerberg, Gabriella Chauca Strand, Anna Forsberg, Ulf Strömberg
Förderung
- Swedish Research Council for Health, Working Life and Welfare
Zitieren
APA
Bonander, C., Westerberg, M., Chauca Strand, G., Forsberg, A., & Strömberg, U. (2024). Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkae043
Vancouver
Bonander C, Westerberg M, Chauca Strand G, Forsberg A, Strömberg U. Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield. JNCI Cancer Spectrum. 2024. doi:10.1093/jncics/pkae043
BibTeX
@article{Bonander2024,
author = {Bonander, Carl and Westerberg, Marcus and Chauca Strand, Gabriella and Forsberg, Anna and Strömberg, Ulf},
title = {Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield},
journal = {JNCI Cancer Spectrum},
year = {2024},
doi = {10.1093/jncics/pkae043}
}
EUVIMED